Advanced search
Publication Cover
OncoImmunology Volume 13, 2024 - Issue 1
Submit an article Journal homepage
1,187
Views
0
CrossRef citations to date
0
Altmetric
Original research

LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8+ T cells for improving anti-PD-1 antibody therapy

Jiqi Shana Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Wei Jinga Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Yu Pinga Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Chunyi Shena Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Dong Hana Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Fengsen Liua Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Yaqing Liua Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
,
Congcong Lia Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, ChinaView further author information
&
Yi Zhanga Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;b Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, China;c College of Life Science, Zhengzhou University, Zhengzhou, Henan, China;d Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;e State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, Henan, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9861-4681View further author information
ORCID Icon show all
Article: 2293511 | Received 20 Aug 2023, Accepted 07 Dec 2023, Published online: 14 Dec 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.